Close Menu

NEW YORK – A team of German researchers in collaboration with Qiagen has built a workflow to analyze genomic and transcriptomic data in parallel from multiple analytes including circulating tumor cells (CTCs), circulating cell-free tumor DNA (cfDNA), and extracellular vesicles (EVs) from a minimal blood volume sample.

The team has now begun analyzing additional analytes in HER2-positive breast cancer patients and will present preliminary results at the American Association of Cancer Research Meeting in May.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

A study of Great Danes homes in on a genomic region linked to fearfulness.

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.